GPRO Stock UPDATES Gopro Inc. (GPRO) 77.10 11/02/2014 21:55:

New Post Public Reply Private Reply Replies (0) Message Board

Nov 2, 2014 at 10:55 PM

Gopro Inc. (GPRO) 77.10 $GPRO

GoPro, Inc. Earnings: The Question Investors Need to Ask
Jamal Carnette, The Motley Fool - Motley Fool - Fri Oct 31, 4:34PM CDT
GoPro investors have a lot riding on these three camcorders. Source: GoPro. On Thursday, GoPro reported a fantastic third quarter, defying skeptics and giving shareholders reason to rejoice. Shares of the company popped nearly 15% in Friday's...
GPRO: 77.10 (+8.85)

Market News: LinkedIn Corp, Groupon Inc, GoPro Inc
at The Street - Fri Oct 31, 3:39PM CDT
The Bank of Japan tripled its exchange-traded funds and real estate investment trusts purchases and accelerated its government bond-buying activityThe stock markets in the United States gained driven ...
GPRO: 77.10 (+8.85), LNKD: 228.96 (+26.06), GRPN: 7.31 (+1.32)

GoPro Jumps on Earnings, Groupon Skyrockets: Tech Winners & Losers
at The Street - Fri Oct 31, 3:29PM CDT
Groupon soared more than 20% after receiving a price target increase from Credit Suisse, while GoPro soared following its third quarter report.
GPRO: 77.10 (+8.85), GRPN: 7.31 (+1.32)

Stocks End Week On Fine Note; LinkedIn Surges On Earnings
at Investor's Business Daily - Fri Oct 31, 3:29PM CDT
The market enjoyed another shot of institutional buying Friday, cheered by additional -- and unexpected -- stimulus measures by the Bank of Japan. Another round of healthy earnings reports and a rise in U.S. consumer confidence also fueled positive...
AMBA: 44.29 (+2.49), TSLA: 241.70 (+3.04), GPRO: 77.10 (+8.85), ACT: 242.74 (-0.47), FRGI: 55.15 (+0.79), LNKD: 228.96 (+26.06), JAZZ: 168.84 (-0.98), FLT: 150.56 (+8.01), EPAM: 47.74 (+0.60), REGN: 393.72 (+0.92), BABA: 98.60 (-0.13)

S&P, Dow Close at Record Highs as U.S. Economic Strength Trumps Global Fears
at The Street - Fri Oct 31, 3:19PM CDT
Global woes plagued markets at the outset of October, but markets are poised to close at a record-high amid strong U.S. economic prospects.
SBUX: 75.56 (-1.76), GPRO: 77.10 (+8.85), C: 53.53 (+0.38), XOM: 96.71 (+2.26), ABBV: 63.46 (+2.28), CVX: 119.95 (+2.75)

'Fast Money' Recap: A Strong Finish for October but Rally Not Done
at The Street - Fri Oct 31, 1:25PM CDT
Investors should use some caution moving forward, but the rally in U.S. stocks doesn't appear to be finished.
GPRO: 77.10 (+8.85), F: 14.09 (+0.14), C: 53.53 (+0.38), BAC: 17.16 (+0.13), TLT: 119.25 (-0.31), HPQ: 35.88 (+0.56), MS: 34.95 (+0.43), SBUX: 75.56 (-1.76), VLO: 50.09 (+1.24), GT: 24.23 (+0.69), SPY: 201.66 (+2.28), GS: 189.99 (+3.02), QQQ: 101.40 (+1.38), ESV: 40.59 (+0.64), DIA: 173.45 (+1.85), GM: 31.40 (+0.62), IWM: 116.56 (+1.69), GRPN: 7.31 (+1.32)

5 Things Garmin Ltd.'s Management Wants You to Know
Sam Mattera, The Motley Fool - Motley Fool - Fri Oct 31, 1:14PM CDT
Shares of GPS giant Garmin fell more than 5% on Wednesday October 29, 2014 after the company posted its third-quarter results . Although Garmin's earnings and revenue exceeded expectations, investors may have been disappointed with the decline of...
GPRO: 77.10 (+8.85), GRMN: 55.48 (+1.34), AAPL: 108.00 (+1.02)

Stock Market Today: October Stock Scare Turns to Rally as Dow Hits Record
at The Street - Fri Oct 31, 12:58PM CDT
Fears of an October stock market slump are a distant memory as central banks print money and the U.S. economy kicks into gear.
SBUX: 75.56 (-1.76), GPRO: 77.10 (+8.85), C: 53.53 (+0.38), XOM: 96.71 (+2.26), ABBV: 63.46 (+2.28), CVX: 119.95 (+2.75)

GoPro Q3 Earnings Grow on Strong HERO4 Camera Demand - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Oct 31, 12:50PM CDT
Profits in the quarter were primarily driven by strong demand for the company's Hero 4 line of cameras and accessories.
SKUL: 8.34 (-0.07), GPRO: 77.10 (+8.85), ADNC: 3.73 (-2.15)

Stocks Extend Gains After Bank of Japan Surprise Move
at Investor's Business Daily - Fri Oct 31, 10:51AM CDT
Stocks extended their gains going into the lunch hour Friday. Major indexes came out of the blocks at full sprint, thanks to an unexpected overnight announcement by the Bank of Japan to increase asset purchases to shore up the country's sagging...
AMBA: 44.29 (+2.49), GPRO: 77.10 (+8.85), XOM: 96.71 (+2.26), CVX: 119.95 (+2.75)

Stock Market Today: Stocks Hit New Highs as Japan Boosts Stimulus
at The Street - Fri Oct 31, 10:32AM CDT
U.S. stocks surge Friday morning after the Bank of Japan unexpectedly increases its annual stimulus targets.
SBUX: 75.56 (-1.76), GPRO: 77.10 (+8.85), C: 53.53 (+0.38), XOM: 96.71 (+2.26), ABBV: 63.46 (+2.28), CVX: 119.95 (+2.75)

GoPro (GPRO) Earnings Report: Q3 2014 Conference Call Transcript
at The Street - Fri Oct 31, 10:28AM CDT
The following GoPro (GPRO) conference call took place on October 30, 2014, 05:00 PM ET. This is a transcript of that earnings call:
GPRO: 77.10 (+8.85)

Stocks Surge At Starting Bell; Mylan, Expedia, GoPro Rocket
at Investor's Business Daily - Fri Oct 31, 9:36AM CDT
Stocks sprinted out of the starting gate Friday, with economic news, quarterly reports and international markets all adding lift. The Nasdaq staked out an early lead, up 1.2%, asMylan (MYL), Analog Devices (ADI) and Expedia (EXPE) all opened more...
AMBA: 44.29 (+2.49), GPRO: 77.10 (+8.85), EXPE: 84.97 (+4.24), ADI: 49.62 (+2.62), MYL: 53.55 (+1.18), MELI: 136.15 (+20.95)

GoPro Surges 15 Percent On 3Q Report: Looking Behind the Lights
at The Street - Fri Oct 31, 9:02AM CDT
Last night, GoPro GPRO reported a third quarter that caused the stock to shoot up a quick 15 percent. Here's why... and where the stock can go from here
GPRO: 77.10 (+8.85), NDLS: 22.83 (+0.56), GRMN: 55.48 (+1.34), TCS: 18.44 (+0.13), AAPL: 108.00 (+1.02)

Market Activity, Joint Venture Update, Dividend Declaration, and Quarterly Results - Research Reports on GoPro, Coach, Philip Morris, Goodyear and PACCAR
PR Newswire - Fri Oct 31, 8:10AM CDT
Today, Analysts Review released its research reports regarding GoPro, Inc. (NASDAQ: GPRO), Coach, Inc. (NYSE: COH), Philip Morris International, Inc. (NYSE: PM), The Goodyear Tire & Rubber Company (NASDAQ: GT) and PACCAR Inc. (NASDAQ: PCAR). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/7601-100free.
PM: 89.01 (+0.66), GPRO: 77.10 (+8.85), GT: 24.23 (+0.69), COH: 34.38 (+0.11), PCAR: 65.32 (+1.47)

Stocks Head For Solid Start; MercadoLibre And GoPro Soar
at Investor's Business Daily - Fri Oct 31, 8:04AM CDT
Stock futures swept up powerful gains ahead of Friday's open, set to open the last day of October with a kick. Dow futures soared 168.58 points above fair market value, although slightly below earlier highs. S&P 500 futures were up a strong 20.9...
GPRO: 77.10 (+8.85), LNKD: 228.96 (+26.06), MELI: 136.15 (+20.95)

Stock Market Today: S&P 500 Is Poised to Open Near Record High on Expanded Bank of Japan Stimulus
at The Street - Fri Oct 31, 7:50AM CDT
U.S. stock futures surge Friday after the Bank of Japan unexpectedly increases its annual stimulus targets by 10 trillion yen to 80 trillion ($717 billion).
SBUX: 75.56 (-1.76), GPRO: 77.10 (+8.85), C: 53.53 (+0.38), XOM: 96.71 (+2.26), ABBV: 63.46 (+2.28), CVX: 119.95 (+2.75)

GoPro (GPRO) Stock Surges Today on Holiday Sales Forecast
at The Street - Fri Oct 31, 7:11AM CDT
The maker of mountable and wearable cameras and accessories forecast better-than-expected holiday quarter sales.
GPRO: 77.10 (+8.85)

'Fast Money' Recap: A Disappointing Development for Citi Investors
at The Street - Fri Oct 31, 4:00AM CDT
The trading panel discussed which banks should be your investment choice and earnings from GoPro, Starbucks and LinkedIn.
SBUX: 75.56 (-1.76), GPRO: 77.10 (+8.85), GS: 189.99 (+3.02), LNKD: 228.96 (+26.06), C: 53.53 (+0.38), WFC: 53.09 (+0.63), TASR: 18.84 (+1.14), TLT: 119.25 (-0.31), MBLY: 52.01 (+1.11), MS: 34.95 (+0.43)

Taser spikes on Q3 earnings
at Investor's Business Daily - Thu Oct 30, 6:17PM CDT
Shares of the security device maker jumped as much as 16% early Thu. after it said Q3 EPS climbed 40% to 14 cents, beating estimates by 5 cents a share. Revenue rose 26.1% vs. Q3 '13, to $44.4 mil, well above forecasts for $39.3 mil. Taser's (TASR)...
GPRO: 77.10 (+8.85), TASR: 18.84 (+1.14), DGLY: 14.62 (-0.07)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Lilly's Sofe-M Shakes Up Ovarian Cancer Treatment

Ovarian Cancer Treatment Sees a New Challenger Alright, folks, Eli Lilly (NYSE:LLY) is stepping up with their latest findings in ovarian cancer treatment, and it's got plenty of people in a buzz. They've dropped new data for their investigational drug, Sofetabart mipitecan, or 'Sofe-M' for short, which targets this unrelenting disease with a punch that’s hard to ignore....

ASTS Faces Crucial Deadline Amidst Legal Turmoil

Ah, the ticking clock in the world of stock investments, where a nifty little thing called a class action lawsuit can flip your investment on its head. Right now, AST SpaceMobile (NASDAQ: ASTS) investors are staring down the barrel of one such lawsuit. With the November 13, 2026, deadline looming, it's time to sort the facts from the muck. Pins and Needles for ASTS...

World Young Scientist Summit 2026 in Wenzhou Kicks Off

Young Minds Meet AI Innovation Crack open the playbook, and it's clear: young brains from across the globe are gathering in Wenzhou, Zhejiang, China, to wrangle with AI and chart the course of science toward a sustainable future. The World Young Scientist Summit 2026 isn't just a parade of speeches and accolades. Nah, it's a deep dive into where innovative minds believe...

Survivors Secure $800M Settlement with NY Archdiocese

Massive Settlement: A Long-Awaited Justice Here's a different kind of news that's hitting like a thunderbolt. Over 1,300 survivors of abuse have finally struck a landmark deal with the Archdiocese of New York. Not only are the numbers staggering, but the relief for these individuals is palpable. We're talking about more than $800 million on the table here. That's some...

Bio-Thera's New Data: A Game Changer for NSCLC?

A Fresh Look at Lung Cancer Solutions There's fresh meat on the oncology block, with Bio-Thera Solutions swinging for the fences at ESMO 2026, spotlighting promising Phase 2 clinical data for their combo treatment in first-line non-small cell lung cancer (NSCLC). If you're tuned into the biopharmaceutical sector or just keeping tabs on global health romps, this news sets...

Swanson Nexus Pro Launch: Boost for Dietitians

By Lucas Young Updated Oct 24, 2026 Category News Views 160

Swanson Enters the Education Arena for Nutritionists Swanson Vitamins is mixing things up again! This time, they're launching something called Swanson Vitamins Nexus Pro, aimed squarely at the registered dietitians and licensed nutritionists crowd. Starting out as the place to grab your basic vitamins, Swanson's not resting on their supplement laurels. No, siree. They've...

CSTS Unveils PremierX in NYC: A Bold Entertainment Move

Welcome to the New Era of Entertainment Out of the blockbusters and into the open air, eh? On October 30, 2026, CSTS Enterprises flipped the New York skyline into a canvas for their grand kickoff of PremierXTM—a live entertainment brand poised to redefine how we gobble up our music, sport, and art. Now, there's a shot of adrenaline New Yorkers weren't exactly begging...

Alaska's Insurance Maze: Coverage Over Cheap Policies

Beyond Premiums: Assessing Real Coverage Needs The Alaskan wilderness isn't just home to stunning views; it's also a land where insurance needs to go beyond the average cookie-cutter policy. You'd think the cheapest option would suffice, but that's where residents might trip into financial quicksand. Devery Prince, a seasoned insurance principal, sheds light on why...

Axon Body 5: A Leap Forward in AI for Public Safety

Axon Raises the Stakes with Body 5 Camera Boy, oh boy, Axon's dropped a bombshell with the Body 5. We're talking a colossal leap into the AI era for public safety, and if you're in the biz, you can't just shrug this one off. We're looking at 25 times the AI processing power compared to Axon's old units. That's right, I said twenty-five. Real-time situational awareness in...

Apalutamide Boosts Outlook for Prostate Cancer Treatment

Fresh Findings on High-Risk Prostate Cancer Treatments In an industry that often feels like a game of chess, Johnson & Johnson's recent news unveils another one of their strategic moves with the announcement of breakthrough results from their Phase 3 PROTEUS substudy. Turns out, ERLEADA®, their apalutamide treatment, isn't just another pawn; it's a potential...